Prognostic value of blood eosinophils for predicting survival and treatment outcomes in people with non-small cell lung cancer.

Date publication

février 2025

Journal

The Cochrane database of systematic reviews

Auteurs

Membres identifiés du Cancéropôle Est :
Pr WESTEEL Virginie

Tous les auteurs :
Sultana H, De Vos T, Malouf R, Calais F, Marchal C, Eberst G, Westeel V, Barnig C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39918122

Résumé

This is a protocol for a Cochrane Review (prognosis). The objectives are as follows: To assess the prognostic value of measuring pretreatment baseline blood eosinophil levels in adults receiving systemic treatment for any stage of non-small cell lung cancer.

Mots clés

Humans, Carcinoma, Non-Small-Cell Lung, mortality, Eosinophils, Lung Neoplasms, mortality, Prognosis, Systematic Reviews as Topic, Leukocyte Count, Treatment Outcome

Référence

Cochrane Database Syst Rev. 2025 02 7;2(2):CD015783